Companies: 10,795·Total market cap: $144.5T
United Therapeutics Corporation

United Therapeutics Corporation

UTHRNASDAQHealthcare● Active
$549.87
+$2.18(+0.40%)
Market Cap$23.3B
P/E Ratio
52W High$609.35
52W Low$272.12
Overview

United Therapeutics Corporation (UTHR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

UTHR · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.56B -52.3% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$1.56B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-52.3%
vs prior fiscal year
Latest Quarter
$2.15B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$1.56BCash on Hand
Total Debt$0Total Debt
Net Cash / Net Debt+$1.56BNet Cash Position
Cash vs Debt Ratio
Cash 100%Debt 0%

United Therapeutics Corporation has a net cash position of $1.56B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$1.56B$0 = +$1.56B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
UTHR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$1.56B-52.3%
Dec 31, 2024$3.27B+9.1%
Dec 31, 2023$2.99B+5.5%
Dec 31, 2022$2.84B+47.0%
Dec 31, 2021$1.93B+5.2%
UTHR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
United Therapeutics Corporation
United Therapeutics CorporationYOU
UTHR
$1.56B6.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

United Therapeutics Corporation (UTHR) cash on hand as of December 31, 2025 is $1.56B, comprising $1.56B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as United Therapeutics Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as United Therapeutics Corporation cash reserves or cash position.

United Therapeutics Corporation annual cash on hand history shows decreased -52.3% in 2025: decreased -52.3% in 2025. United Therapeutics Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

United Therapeutics Corporation carries total debt of $0 against cash of $1.56B, resulting in a net cash position of +$1.56B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

UTHR cash on hand · 5 questions

As of December 31, 2025, United Therapeutics Corporation (UTHR) has $1.56B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.56B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2.15B. Data sourced from the annual 10-K filing via FMP.

UTHR cash on handUTHR cash reservesUTHR cash 2025how much cash does UTHR have

Source: FMP /balance-sheet-statement · US GAAP · United Therapeutics Corporation · United Therapeutics Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025